Clinical Trials

Knee Osteoarthritis (KOA)

Liver Cancer (HCC)



NASDAQ: CBMGRobust product pipelines addressing multiple large market opportunities


CBMG has a research, development and manufacturing team with more than 30 years of relevant experience in China, England, and the USA. CBMG is a leading cell therapy...


CBMG in the Press

Currently, patients suffering from osteoarthritis in China number approximately 56 million people